XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
OPERATING ACTIVITIES      
Net income (loss) $ 6,731 $ 3,853 $ (10,693)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:      
Depreciation expense 889 1,081 1,354
Gain on sale of equipment and property   (37) (15)
Gain on benefit plan financing arrangement (2,025)    
Stock-based compensation expense 1,296 1,542 1,645
Excess tax benefits for share-based payments (77)   (453)
Deferred income tax benefit (76) (132) (854)
(Increase) decrease in assets:      
Accounts receivable (1,031) 87 4,310
Inventories (3,025) (2,395) 2,966
Prepaid expenses and other current assets (10) 1,332 (1,102)
Income taxes receivable 558 5,823 (3,325)
Other non-current assets (67) (20) (733)
Increase (decrease) in liabilities:      
Accounts payable 1,108 (88) 535
Income taxes payable 327 68  
Other accrued expenses (1,281) (163) (3,570)
Other long-term liabilities (21) (72) 899
Net cash provided by (used for) operating activities 3,296 10,879 (9,036)
INVESTING ACTIVITIES      
Capital expenditures (357) (191) (85)
Proceeds from sale of assets   41 15
Proceeds from benefit plan financing arrangement 3,671    
Re-investment in benefit plan financing arrangement (3,671)    
Sales and maturities of marketable securities 24,904 25,579 22,344
Purchases of marketable securities (36,106) (29,147) (14,858)
Net cash (used for) provided by investing activities (11,559) (3,718) 7,416
FINANCING ACTIVITIES      
Payment of dividends     (369)
Cash paid for common stock purchased and retired (447) (244) (537)
Excess tax benefits for share-based payments 77   453
Proceeds received upon exercise of stock options 54 45 24
Net cash used for financing activities (316) (199) (429)
Net (decrease) increase in cash and cash equivalents (8,579) 6,962 (2,049)
Cash and cash equivalents at beginning of year 9,535 2,573 4,622
Cash and cash equivalents at end of year $ 956 $ 9,535 $ 2,573